Advertisement

Topics

Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle

2017-06-04 19:40:33 | BioPortfolio

Summary

The company suggests a new concept of treatment for PE: Transient inhibition of striated muscle contraction by a transcutaneous stimulation device. This study aim is to evaluate the safety of delivering increasing electrical stimulation intensities to the subject's perineum, using a TENS technique and equipment, followed by a 72-hour postoperative follow-up.

Study Design

Conditions

Premature Ejaculation

Intervention

TENS Stimulator

Location

Rambam Health Care Campus
Haifa
Israel

Status

Active, not recruiting

Source

Virility Medical Ltd.

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-06-04T19:40:33-0400

Clinical Trials [403 Associated Clinical Trials listed on BioPortfolio]

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in ...

Effectiveness of Strategies to Address Premature Ejaculation in General Medicine

Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality ...

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

The purpose of this study is to determine the effectiveness of IX-01 in men with lifelong premature ejaculation.

Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation

The objectives of the present study aims to evaluate the safety and efficacy of Silodosin in a population of patients wih Premature Ejaculation (PE). Coupled with efficient diagnosis, it i...

Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

To determine whether UK-390,957 is an effective and safe treatment for premature ejaculation.

PubMed Articles [899 Associated PubMed Articles listed on BioPortfolio]

Efficacy of treatment with pseudoephedrine in men with retrograde ejaculation.

The use of pseudoephedrine, an alpha agonist, for the treatment of retrograde ejaculation is well-known, however, there is no clear consensus from the literature regarding its efficacy and treatment p...

Re: Resiniferatoxin for treatment of lifelong premature ejaculation: A preliminary study.

Editorial Comment to Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.

Significant changes of T2 value in the peripheral zone and seminal vesicles after ejaculation.

To analyse the quantitative changes of the prostate and seminal vesicles (SV) on magnetic resonance imaging (MRI) after ejaculation.

TENS Alleviates Muscle Weakness Attributable to Attenuation of Ia Afferents.

Quadriceps weakness is a notable problem following knee damage. Research has shown effectiveness of TENS in improving Quadriceps weakness associated with arthrogenic muscle inhibition. However, these ...

Medical and Biotech [MESH] Definitions

The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.

A type of cardiac arrhythmia with premature contractions of the HEART VENTRICLES. It is characterized by the premature QRS complex on ECG that is of abnormal shape and great duration (generally >129 msec). It is the most common form of all cardiac arrhythmias. Premature ventricular complexes have no clinical significance except in concurrence with heart diseases.

Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).

A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.

The premature cessation of menses (MENSTRUATION) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.

More From BioPortfolio on "Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle"

Quick Search
Advertisement
 

Searches Linking to this Trial